Global Nanotechnology in Healthcare Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Executive Summary
According to GRD Survey data, the global Nanotechnology in Healthcare market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Nanotechnology in Healthcare market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Nanotechnology in Healthcare in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Others
Market Snapshot, By Application
Anticancer
CNS Product
Anti-infective
Others
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
UCB
Teva Pharmaceuticals
Stryker
Smith & Nephew
Shire
Sanofi
Roche
Pfizer
Merck & Co
Leadiant Biosciences
Kyowa Hakko Kirin
Johnson & Johnson
Ipsen
Gilead Sciences
Endo International
Celgene
Biogen
Amgen
Abbott
3M Company
The study objectives of this report are:
To study and analyze the global Nanotechnology in Healthcare market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Nanotechnology in Healthcare market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Nanotechnology in Healthcare manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nanotechnology in Healthcare market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Nanotechnology in Healthcare submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Nanotechnology in Healthcare are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Nanotechnology in Healthcare Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Nanotechnology in Healthcare Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Nanotechnology in Healthcare
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Application One
3.2.2 Major Buyers in Application Two
3.2.1 Major Buyers in Application Three
4 Market Segment: by Type
4.1 Nanotechnology in Healthcare Type Introduction
4.1.1 Nanomedicine
4.1.2 Nano Medical Devices
4.1.3 Nano Diagnosis
4.1.4 Others
4.2 Global Nanotechnology in Healthcare Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 Nanotechnology in Healthcare Type Introduction
5.1.1 Anticancer
5.1.2 CNS Product
5.1.3 Anti-infective
5.1.3 Others
5.2 Global Nanotechnology in Healthcare Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Nanotechnology in Healthcare Market by Region
6.2 North America Nanotechnology in Healthcare Market 2016-2021
6.3 Europe Nanotechnology in Healthcare Market 2016-2021
6.4 Asia Pacific Nanotechnology in Healthcare Market 2016-2021
6.5 South America Nanotechnology in Healthcare Market 2016-2021
6.6 Middle East and Africa Nanotechnology in Healthcare Market 2016-2021
7 North America
7.1 North America Nanotechnology in Healthcare Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Nanotechnology in Healthcare Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Nanotechnology in Healthcare Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Nanotechnology in Healthcare Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Nanotechnology in Healthcare Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
3.1 UCB
3.1.1 UCB Company Information
3.1.2 UCB Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.1.3 UCB Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.1.4 UCB Key Development
3.2 Teva Pharmaceuticals
3.2.1 Teva Pharmaceuticals Company Information
3.2.2 Teva Pharmaceuticals Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.2.3 Teva Pharmaceuticals Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.2.4 Teva Pharmaceuticals Key Development
3.3 Stryker
3.3.1 Stryker Company Information
3.3.2 Stryker Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.3.3 Stryker Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.3.4 Stryker Key Development
3.4 Smith & Nephew
3.4.1 Smith & Nephew Company Information
3.4.2 Smith & Nephew Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.4.3 Smith & Nephew Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.4.4 Smith & Nephew Key Development
3.5 Shire
3.5.1 Shire Company Information
3.5.2 Shire Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.5.3 Shire Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.5.4 Shire Key Development
3.6 Sanofi
3.6.1 Sanofi Company Information
3.6.2 Sanofi Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.6.3 Sanofi Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.6.4 Sanofi Key Development
3.7 Roche
3.7.1 Roche Company Information
3.7.2 Roche Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.7.3 Roche Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.7.4 Sanofi Key Development
3.9 Merck & Co
3.9.1 Merck & Co Company Information
3.9.2 Merck & Co Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.9.3 Merck & Co Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.9.4 Merck & Co Key Development
3.8 Pfizer
3.8.1 Pfizer Company Information
3.8.2 Pfizer Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.8.3 Pfizer Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.8.4 Pfizer Key Development
3.11 Kyowa Hakko Kirin
3.11.1 Kyowa Hakko Kirin Company Information
3.11.2 Kyowa Hakko Kirin Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.11.3 Kyowa Hakko Kirin Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.11.4 Kyowa Hakko Kirin Key Development
3.12 Johnson & Johnson
3.12.1 Johnson & Johnson Company Information
3.12.2 Johnson & Johnson Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.12.3 Johnson & Johnson Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.12.4 Johnson & Johnson Key Development
3.13 Ipsen
3.13.1 Ipsen Company Information
3.13.2 Ipsen Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.13.3 Ipsen Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.13.4 Ipsen Key Development
3.14 Gilead Sciences
3.14.1 Gilead Sciences Company Information
3.14.2 Gilead Sciences Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.14.3 Gilead Sciences Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.14.4 Gilead Sciences Key Development
3.15 Endo International
3.15.1 Endo International Company Information
3.15.2 Endo International Nanotechnology in Healthcare Product Portfolio, Specification and Application
3.15.3 Endo International Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
3.15.4 Endo International Key Development
3.17 Biogen
3.18 Amgen
3.19 Abbott
3.20 3M Company
13 Global Nanotechnology in Healthcare Market Forecast by Region by Type and by Application
13.1 Global Nanotechnology in Healthcare Revenue Forecast 2022-2027
13.2 Global Nanotechnology in Healthcare Forecast by Regions
13.3 Global Nanotechnology in Healthcare Forecast by Type
13.4 Global Nanotechnology in Healthcare Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global Nanotechnology in Healthcare Production Specifications
Table 2: Drivers in Nanotechnology in Healthcare Market
Table 3: Restraints Nanotechnology in Healthcare Market
Table 4: Opportunity in Nanotechnology in Healthcare Market
Table 5: Comparion of Alternative and Nanotechnology in Healthcare
Table 6: Nanotechnology in Healthcare Raw Materials Key Suppliers List
Table 7: Nanotechnology in Healthcare Distributors List
Table 8: Nanotechnology in Healthcare Major Buyers in Application One
Table 9: Nanotechnology in Healthcare Major Buyers in Application Two
Table 10: Nanotechnology in Healthcare Major Buyers in Application Three
Table 11: Global Nanotechnology in Healthcare Revenue (Million USD) by Type 2016-2021
Table 12: Global Nanotechnology in Healthcare Revenue Market Share by Type 2016-2021
Table 18: Global Nanotechnology in Healthcare Revenue (Million USD) by Application 2016-2021
Table 19: Global Nanotechnology in Healthcare Revenue Market Share by Application 2016-2021
Table 20: Global Nanotechnology in Healthcare Revenue (Million USD) by Region 2016-2021
Table 21: Global Nanotechnology in Healthcare Revenue Market Share by Region 2016-2021
Table 22: North America Nanotechnology in Healthcare Revenue (Million USD) by Country 2016-2021
Table 23: North America Nanotechnology in Healthcare Revenue Market Share by Country 2016-2021)
Table 24: Europe Nanotechnology in Healthcare Revenue (Million USD) by Country 2016-2021
Table 25: Europe Nanotechnology in Healthcare Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Nanotechnology in Healthcare Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Nanotechnology in Healthcare Revenue Market Share by Country 2016-2021)
Table 28: South America Nanotechnology in Healthcare Revenue (Million USD) by Country 2016-2021
Table 29: South America Nanotechnology in Healthcare Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Nanotechnology in Healthcare Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Nanotechnology in Healthcare Revenue Market Share by Country 2016-2021)
Table 32 UCB Company Information
Table 33 UCB Nanotechnology in Healthcare Product Portfolio, Specification and Application
Table 34 UCB Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
Table 35 Teva Pharmaceuticals Company Information
Table 36 Teva Pharmaceuticals Nanotechnology in Healthcare Product Portfolio, Specification and Application
Table 37 Teva Pharmaceuticals Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
Table 38 Stryker Company Information
Table 39 Stryker Nanotechnology in Healthcare Product Portfolio, Specification and Application
Table 40 Stryker Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
Table 41 Smith & Nephew Company Information
Table 42 Smith & Nephew Nanotechnology in Healthcare Product Portfolio, Specification and Application
Table 43 Smith & Nephew Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
Table 44 Shire Company Information
Table 45 Shire Nanotechnology in Healthcare Product Portfolio, Specification and Application
Table 46 Shire Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
Table 47 Sanofi Company Information
Table 48 Sanofi Nanotechnology in Healthcare Product Portfolio, Specification and Application
Table 49 Sanofi Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
Table 50 Roche Company Information
Table 51 Roche Nanotechnology in Healthcare Product Portfolio, Specification and Application
Table 52 Roche Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
Table 53 Pfizer Company Information
Table 54 Pfizer Nanotechnology in Healthcare Product Portfolio, Specification and Application
Table 55 Pfizer Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
Table 56 Merck & Co Company Information
Table 57 Merck & Co Nanotechnology in Healthcare Product Portfolio, Specification and Application
Table 58 Merck & Co Nanotechnology in Healthcare Revenue and Gross Margin (2019-2021)
Table 59: Global Nanotechnology in Healthcare Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Nanotechnology in Healthcare Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Nanotechnology in Healthcare Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Nanotechnology in Healthcare Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Nanotechnology in Healthcare Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Nanotechnology in Healthcare Revenue Market Share Forecast by Application (2022-2027)
Tables and Figures
List of Figures
Figure 1: Nanotechnology in Healthcare Picture
Figure 2: Global Nanotechnology in Healthcare Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Nanotechnology in Healthcare Industry Life Cycle
Figure 5: Product Picture of Nanomedicine
Figure 6: Product Picture of Nano Medical Devices
Figure 9: Global Nanotechnology in Healthcare Revenue Market Share by Type, 2020
Reason to Buy
- Current and future of Service & Software Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Service & Software Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets